StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) stock

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.58+0.82 (+6.43%)

Close on Nov 17, 2026Market cap $476.21MP/E –Yield –

Fennec Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Fennec Pharmaceuticals's total debt was $25.00M at Sep 30, 2022. For fiscal 2021 it was $5.00M.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$5.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2022Sep 30, 2022$25.00M–
Q2 FY2022Jun 30, 2022$5.00M–
Q1 FY2022Mar 31, 2022$5.00M–
Q4 FY2021Dec 31, 2021$5.00M–

More Fennec Pharmaceuticals figures

See a number that looks wrong?